Project Grant R21DA062929
Award Date 6/15/26
Completion Date 5/31/28
Dollars Obligated $427K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Richmond, VA 23298, USA
Similar Awards
- Federal Project Grant Award Summary Virginia Commonwealth University (VCU) received a $931,500 project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, with completion anticipated May 31, 2030. The award supports research development of novel mu opioid receptor (MOR) selective bitopic ligands designed to counteract the effects of synthetic opioids such as fentanyl and other novel synthetic opioids...
- Federal Project Grant Award Summary Virginia Commonwealth University received a $1,406,056 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2025, through March 31, 2029. The award supports secondary data analyses investigating vulnerability to substance use transitions and trajectories in adolescents participating in the Adolescent Brain Cognitive Development (ABCD) Study, a longitudinal national...
- Federal Grant Award Summary Virginia Commonwealth University received a $1.86M Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, with completion targeted for April 30, 2030. This mechanistic research study investigates the role of the orexin system and insomnia within a buprenorphine opioid use disorder (OUD) treatment sample. The research aims to identify neurobiological mechanisms linking poor OUD...
- Federal Project Grant Award Summary Boston University Medical Campus received a $109,076 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded January 9, 2026, with completion targeted for July 31, 2029. The grant supports basic neuroscience research investigating the role of G alpha Z (GAZ) protein in mediating behavioral responses to opioids. The research aims to elucidate how GAZ signaling in specific brain...
- Federal Grant Award Summary American University received a $476,496 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 15, 2025, and concluding July 31, 2028. The grant funds fundamental neuroscience research investigating opioid signaling mechanisms in reward-guided decision-making within the rat prefrontal cortex, specifically the prelimbic area. The research employs a two-alternative forced choice...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $466,363 Project Grant effective June 1, 2026 through April 30, 2031 under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports fundamental research to characterize and exploit allosteric crosstalk among pain receptors, specifically examining how endogenous neuromodulators such as endocannabinoids and oxytocin allosterically modulate mu-opioid receptor (MOR)...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1,980,870 Project Grant to The Washington University, Office of Sponsored Research Services, effective August 1, 2025, through April 30, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds preclinical research to advance the analgesic potential of novel peripherally-restricted cannabinoid type 1 receptor (CB1R) ligands for pain management. The research addresses a critical gap...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Washington University a $1,964,283 Project Grant effective August 15, 2025, through April 30, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative will investigate mesolimbic dopaminergic adaptations underlying altered reward sensitivity in chronic neuropathic pain (CNP), with research to be conducted at the university's St. Louis, Missouri facility. The project...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke awarded the University of Massachusetts Lowell a $1,009,623 Project Grant (Drug Use and Addiction Research Programs, CFDA 93.279) effective June 1, 2026, through May 31, 2028. This award funds the discovery and development of novel, non-opioid analgesics derived from marine microbial natural products to address chronic pain, identified as the nation's leading public health crisis affecting over 25 million...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $163,350 under the Drug Use and Addiction Research Programs (CFDA 93.279) to The University of Texas Health Science Center at San Antonio, effective February 15, 2026 through January 31, 2028. This award funds research investigating the molecular regulation of the kappa opioid receptor (KOR) by 14-3-3 gamma, a scaffolding protein that modulates opioid receptor signaling in peripheral neurons. The...